跳至主要内容
临床试验/CTRI/2024/04/064961
CTRI/2024/04/064961尚未招募4 期

A prospective, multi-centre, single-arm, investigator-initiated study to evaluate the safety and performance of Dafodil™ PerICardial BioprosThesis in patients undergoing native/prosthetic Aortic or miTral valvE replacement. - DICTATE

Meril Diagnostics private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients whose valvular disease is sufficiently advanced to warrant
  • replacement of their natural/prosthetic aortic or mitral valve with Dafodil
  • pericardial bioprosthesis or its subsequent advanced version.
  • 2. Patients who are willing to undergo all protocol specific study procedures
  • and follow-up requirements.
  • 3. Patient or his/her Legally Acceptable Representative (LAR) has been
  • informed about the nature of the registry and informed consent for study
  • participation has been obtained from the patient or LAR, as per applicable
  • local requirements.

排除标准

  • 1. Patients who are not willing to provide informed consent form, or whose
  • legal heirs object to their participation in the study
  • 2. Any condition, which, in Investigator’s or heart team’s opinion would
  • preclude safe participation of patients in the study

研究者

发起方
Meril Diagnostics private Limited

相似试验